ResVita Bio
Sarah Moradi Fard is a highly skilled senior scientist with extensive experience in antibody engineering, molecular biology, and biochemistry. Currently employed at ResVita Bio, Sarah previously held positions at Glyphic Biotechnologies, where significant contributions included the establishment of a yeast surface display platform for accurate protein sequencing technology. At the Arnie Charbonneau Cancer Institute, Sarah conducted critical research on DNA repair mechanisms and contributed to various mentorship roles at the University of Calgary, covering advanced genetics and telomere biology. Sarah's educational background includes a Ph.D. in Cellular and Molecular Biology with a focus on cancer biology from the University of Calgary and a B.Sc. in Cell and Molecular Biology from Alzahra University.
This person is not in any teams
ResVita Bio
The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases. ResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.